KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Amortizatization of Intangibles: 2017-2024

Historic Amortizatization of Intangibles for Xenon Pharmaceuticals (XENE) over the last 7 years, with Dec 2024 value amounting to $1.3 million.

  • Xenon Pharmaceuticals' Amortizatization of Intangibles rose 4.76% to $330,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 135.07%. This contributed to the annual value of $1.3 million for FY2024, which is 3.38% up from last year.
  • Per Xenon Pharmaceuticals' latest filing, its Amortizatization of Intangibles stood at $1.3 million for FY2024, which was up 3.38% from $1.2 million recorded in FY2023.
  • In the past 5 years, Xenon Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $1.3 million in FY2024 and a low of $216,000 during FY2020.
  • For the 3-year period, Xenon Pharmaceuticals' Amortizatization of Intangibles averaged around $1.1 million, with its median value being $1.2 million (2023).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first plummeted by 58.86% in 2020, then soared by 48.11% in 2023.
  • Yearly analysis of 4 years shows Xenon Pharmaceuticals' Amortizatization of Intangibles stood at $216,000 in 2020, then reached $819,000 in 2022, then skyrocketed by 48.11% to $1.2 million in 2023, then grew by 3.38% to $1.3 million in 2024.